Calcium-induced apoptosis is delayed by HER1 receptor signalling through the Akt and PLCγ pathways in bladder cancer cells

References

• Cotter TG, Lennon SV, Glynn JG, Martin SJ. Cell death via apoptosis and its relationship to growth, development and differentiation of both tumour and normal cells. Anticancer Res 1990;10:1153–9.
   PubMed Web of Science ®Google Scholar
• Denmeade SR, Isaacs JT. Activation of programmed (apoptotic) cell death for the treatment of prostate cancer. Adv Pharmacol 1996;35:281–306.
   PubMedGoogle Scholar
• Kerr JF, Searle J. Deletion of cells by apoptosis during castration-induced involution of the rat prostate. Virchows Arch B Cell Pathol 1973;13:87–102.
   PubMedGoogle Scholar
• Fleckenstein A, Janke J, Doring HJ, Leder O. Myocardial fiber necrosis due to intracellular Ca overload – a new principle in cardiac pathophysiology. Recent Adv Stud Cardiac Struct Metab 1974;4:563–80.
   PubMedGoogle Scholar
• Murgia M, Giorgi C, Pinton P, Rizzuto R. Controlling metabolism and cell death: at the heart of mitochondrial calcium signalling. J Mol Cell Cardiol 2009;46:781–8.
   PubMed Web of Science ®Google Scholar
• Klapper LN, Kirschbaum MH, Sela M, Yarden Y. Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors. Adv Cancer Res 2000; 77:25–79.
   PubMed Web of Science ®Google Scholar
• Normanno N, Bianco C, Strizzi L, Mancino M, Maiello MR, De Luca A, Caponigro F, Salomon DS. The ErbB receptors and their ligands in cancer: an overview. Curr Drug Targets 2005;6:243–57.
   PubMed Web of Science ®Google Scholar
• Ivanov VN, Hei TK. Combined treatment with EGFR inhibitors and arsenite upregulated apoptosis in human EGFR-positive melanomas: a role of suppression of the PI3K-AKT pathway. Oncogene 2005;24:616–26.
   PubMed Web of Science ®Google Scholar
• Jorissen RN, Walker F, Pouliot N, Garrett TPJ, Ward CW, Burgess AW. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res 2003;284:31–53.
   PubMed Web of Science ®Google Scholar
• Chan KC, Knox WF, Gee JM, Morris J, Nicholson RI, Potten CS, Bundred NJ. Effect of epidermal growth factor receptor tyrosine kinase inhibition on epithelial proliferation in normal and premalignant breast. Cancer Res 2002; 62:122–8.
   PubMed Web of Science ®Google Scholar
• Vicentini C, Festuccia C, Gravina GL, Angelucci A, Marronaro A, Bologna M. Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures. J Cancer Res Clin Oncol 2003;129:165–74.
   PubMed Web of Science ®Google Scholar
• Liu B, Fang M, Schmidt M, Lu Y, Mendelsohn J, Fan Z. Induction of apoptosis and activation of the caspase cascade by anti-EGF receptor monoclonal antibodies in DiFi human colon cancer cells do not involve the c-jun N-terminal kinase activity. Br J Cancer 2000;82:1991–9.
   PubMed Web of Science ®Google Scholar
• Mendelsohn J. Targeting the epidermal growth factor receptor for cancer therapy. J Clin Oncol 2002;20:1S–13S.
   PubMed Web of Science ®Google Scholar
• Johnson JD, Ahmed NT, Luciani DS, Han Z, Tran H, Fujita J, Misler S, Edlund H, Polonsky KS. Increased islet apoptosis in Pdx1+/− mice. J Clin Invest 2003;111:1147–60.
   PubMed Web of Science ®Google Scholar
• Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992;148: 2207–16.
   PubMed Web of Science ®Google Scholar
• Schooler K, Wiley HS. Ratiometric assay of epidermal growth factor receptor tyrosine kinase activation. Anal Biochem 2000;277:135–42.
   PubMed Web of Science ®Google Scholar
• Gan HK, Walker F, Burgess AW, Rigopoulos A, Scott AM, Johns TG. The EGFR tyrosine kinase inhibitor AG1478 increases the formation of inactive untethered EGFR dimers: implications for combination therapy with mab 806. J Biol Chem 2007;282:2840–5.
   PubMed Web of Science ®Google Scholar
• Powis G, Seewald MJ, Gratas C, Melder D, Riebow J, Modest EJ. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues. Cancer Res 1992;52:2835–40.
   PubMed Web of Science ®Google Scholar
• Jackisch C, Hahm HA, Tombal B, McCloskey D, Butash K, Davidson NE, Denmeade SR. Delayed micromolar elevation in intracellular calcium precedes induction of apoptosis in thapsigargin-treated breast cancer cells. Clin Cancer Res 2000;6:2844–50.
   PubMed Web of Science ®Google Scholar
• Petranka J, Wright G, Forbes RA, Murphy E. Elevated calcium in preneoplastic cells activates NF-kappa B and confers resistance to apoptosis. J Biol Chem 2001;276: 37102–8.
   PubMed Web of Science ®Google Scholar
• Milosevic J, Juch F, Storch A, Schwarz J. Low extracellular calcium is sufficient for survival and proliferation of murine mesencephalic neural precursor cells. Cell Tissue Res 2006;324:377–84.
   PubMed Web of Science ®Google Scholar
• Sakaguchi M, Miyazaki M, Takaishi M, Sakaguchi Y, Makino E, Kataoka N, Yamada H, Namba M, Huh NH. S100C/A11 is a key mediator of Ca(2+)-induced growth inhibition of human epidermal keratinocytes. J Cell Biol 2003;163:825–35.
   PubMed Web of Science ®Google Scholar
• Holleran JL, Fourcade J, Egorin MJ, Eiseman JL, Parise RA, Musser SM, White KD, Covey JM, Forrest GL, Pan SS. In vitro metabolism of the phosphatidylinositol 3-kinase inhibitor, wortmannin, by carbonyl reductase. Drug Metab Dispos 2004;32:490–6.
   PubMed Web of Science ®Google Scholar
• Ivanov VN, Hei TK. Combined treatment with EGFR inhibitors and arsenite upregulated apoptosis in human EGFR-positive melanomas: a role of suppression of the PI3K-AKT pathway. Oncogene 2005;24:616–26.
   PubMed Web of Science ®Google Scholar
• Thomas SM, Coppelli FM, Wells A, Gooding WE, Song J, Kassis J, Drenning SD, Grandis JR. Epidermal growth factor receptor-stimulated activation of phospholipase Cgamma-1 promotes invasion of head and neck squamous cell carcinoma. Cancer Res 2003;63:5629–35.
   PubMed Web of Science ®Google Scholar
• Festuccia C, Muzi P, Millimaggi D, Biordi L, Gravina GL, Speca S, Angelucci A, Dolo V, Vicentini C, Bologna M. Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines. Endocr Relat Cancer 2005;12:983–98.
   PubMed Web of Science ®Google Scholar
• Tfelt-Hansen J, Yano S, John MR, Smajilovic S, Chattopadhyay N, Brown EM. High calcium activates the EGF receptor potentially through the calcium-sensing receptor in Leydig cancer cells. Growth Factors 2005;23:117–23.
   PubMed Web of Science ®Google Scholar
• Gauthier ML, Torretto C, Ly J, Francescutti V, O'Day DH. Protein kinase Calpha negatively regulates cell spreading and motility in MDA-MB-231 human breast cancer cells downstream of epidermal growth factor receptor. Biochem Biophys Res Commun 2003;307:839–46.
   PubMed Web of Science ®Google Scholar
• Jain PT, Trump BF. Human breast cancer cell growth inhibition and deregulation of [Ca2+]i by estradiol. Anticancer Drugs 1997;8:283–7.
   PubMed Web of Science ®Google Scholar
• Lauthier F, Taillet L, Trouillas P, Delage C, Simon A. Ursolic acid triggers calcium-dependent apoptosis in human Daudi cells. Anticancer Drugs 2000;11:737–45.
   PubMed Web of Science ®Google Scholar
• Chang HT, Huang JK, Wang JL, Cheng JS, Lee KC, Lo YK, Liu CP, Chou KJ, Chen WC, Su W, Law YP, Jan CR. Tamoxifen-induced increases in cytoplasmic free Ca2+ levels in human breast cancer cells. Breast Cancer Res Treat 2002;71:125–31.
   PubMed Web of Science ®Google Scholar